Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Sigmoid Pharma Ltd.
DescriptionCyclosporine combination
Molecular Target
Mechanism of Action 
Therapeutic ModalityMacrocycle
Latest Stage of DevelopmentPhase I
Standard IndicationGraft-versus-host disease (GvHD)
Indication DetailsTreat Graft-versus-host disease (GvHD)
Regulatory Designation U.S. - Orphan Drug (Treat Graft-versus-host disease (GvHD))

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today